How to beat Diuretics, a weight loss forum
Diuretic manufacturers and distributors have been struggling for years to stay competitive with cheaper generic alternatives, which they claim can lead to more frequent overdoses.
The problem is that a combination of the company’s patent-protected proprietary drugs and a number of other problems make it more difficult for the public to learn about the company, experts said.
On Tuesday, the U.S. Food and Drug Administration will issue a proposed rule that would mandate that manufacturers and pharmacies sell the drugs at a reasonable price and to include warnings about potential complications.
The proposed rule is expected to make the FDA the first federal agency to require that manufacturers offer a warning about the potential health risks associated with Diurets and other weight loss medications, said David Katz, a health policy professor at Boston University who studies the obesity crisis.
It could lead to new rules, said Katie Dettmer, a professor of health law at the University of Chicago School of Law who is an expert on the topic.
“It could put the industry on notice, and they’ll have to be careful not to overcharge the public,” Dettfer said.